Association Between Hypertensive Disorders of Pregnancy and Neurodevelopmental Outcomes Among Offspring

Judith S Brand1,2,3, Deborah A Lawlor2,3, Henrik Larsson4,5

  • 1Clinical Epidemiology and Biostatistics, School of Medical Sciences, Örebro University, Örebro, Sweden.

JAMA Pediatrics
|March 22, 2021
PubMed

Insights

Maternal hypertensive disorders of pregnancy (HDP) are linked to slightly higher risks of autism spectrum disorders (ASDs) and attention-deficit/hyperactivity disorder (ADHD) in offspring. Associations with intellectual disability (ID) and cognitive function appear to be influenced by shared familial factors.

Area of Science:

  • Neuroscience
  • Genetics
  • Public Health

Background:

  • Hypertensive disorders of pregnancy (HDP) are linked to adverse neurodevelopmental outcomes in children.
  • The influence of familial confounding on these associations remains unclear.

Purpose of the Study:

  • To investigate the association between maternal HDP and offspring risks for autism spectrum disorders (ASDs), attention-deficit/hyperactivity disorder (ADHD), and intellectual disability (ID).
  • To examine the impact of HDP on offspring cognitive performance.
  • To differentiate between direct effects and familial confounding using within-sibship analyses.

Main Methods:

  • A Swedish population-based cohort study utilizing national registers.
  • Inclusion of over 1 million individuals from birth cohorts and military conscription records.
  • Analyses included whole-cohort and within-sibship comparisons to account for familial factors.

Main Results:

  • Maternal HDP were associated with increased offspring risks for ASDs (HR, 1.22) and ADHD (HR, 1.10) in whole-cohort analyses.
  • Within-sibship analyses suggested that associations with ID (HR, 1.04) and cognitive performance (mean difference, 0.00) were likely confounded by familial factors.
  • HDP were associated with lower cognitive scores in whole-cohort analysis (mean difference, -0.10).

Conclusions:

  • Maternal HDP are associated with a small increase in the risk of ASDs and possibly ADHD in offspring.
  • Associations between HDP and offspring ID or cognitive performance are likely explained by shared familial (genetic or environmental) factors.
  • These findings highlight the importance of considering familial confounding in studies of pregnancy complications and neurodevelopmental outcomes.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
3.7K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.3K
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
533
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
182
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
309
Neurulation01:30

Neurulation

Neurulation is the embryological process which forms the precursors of the central nervous system and occurs after gastrulation has established the three primary cell layers of the embryo: ectoderm, mesoderm, and endoderm. In humans, the majority of this system is formed via primary neurulation, in which the central portion of the ectoderm—originally appearing as a flat sheet of cells—folds upwards and inwards, sealing off to form a hollow neural tube. As development proceeds, the...
43.7K